ID YOUR IRD INHERITED RETINAL DISEASE GENE TESTING INITIATIVE Trademark
Trademark Overview
On Wednesday, January 25, 2017, a trademark application was filed for ID YOUR IRD INHERITED RETINAL DISEASE GENE TESTING INITIATIVE with the United States Patent and Trademark Office. The USPTO has given the ID YOUR IRD INHERITED RETINAL DISEASE GENE TESTING INITIATIVE trademark a serial number of 87312898. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, March 9, 2023. This trademark is owned by Spark Therapeutics, Inc.. The ID YOUR IRD INHERITED RETINAL DISEASE GENE TESTING INITIATIVE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Genetic testing for medical purposes
General Information
| Serial Number | 87312898 |
| Word Mark | ID YOUR IRD INHERITED RETINAL DISEASE GENE TESTING INITIATIVE |
| Filing Date | Wednesday, January 25, 2017 |
| Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Thursday, March 9, 2023 |
| Registration Number | 5270630 |
| Registration Date | Tuesday, August 22, 2017 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 6, 2017 |
Trademark Statements
| Description of Mark | The mark consists of a circular spiral comprising a solid black circular center surrounded by color polka dots in varying shades of the colors orange, yellow, green, blue, purple, fuchsia, pink and red with the text "ID YOUR IRD INHERITED RETINAL DISEASE GENE TESTING INITIATIVE" appearing in black next to the spiral design with the wording "ID YOUR IRD" all appearing on separate lines with the text "INHERITED RETINAL DISEASE" and "GENE TESTING INITIATIVE" appearing on separate lines below "IRD". |
| Indication of Colors claimed | The color(s) orange, yellow, green, blue, black, purple, fuchsia, pink and red is/are claimed as a feature of the mark. |
| Goods and Services | Genetic testing for medical purposes |
| Disclaimer with Predetermined Text | "INHERITED RETINAL DISEASE" AND "GENE TESTING" |
Classification Information
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, January 28, 2017 |
| Primary Code | 044 |
| First Use Anywhere Date | Wednesday, August 31, 2016 |
| First Use In Commerce Date | Friday, September 30, 2016 |
Trademark Owner History
| Party Name | Spark Therapeutics, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Philadelphia, PA 19104 |
| Party Name | Spark Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Philadelphia, PA 19104 |
| Party Name | Spark Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Philadelphia, PA 19104 |
Trademark Events
| Event Date | Event Description |
| Thursday, March 9, 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Thursday, March 9, 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Thursday, March 9, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, August 23, 2022 | TEAS SECTION 8 & 15 RECEIVED |
| Monday, August 22, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, August 22, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 6, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 6, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 17, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 25, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, April 20, 2017 | ASSIGNED TO EXAMINER |
| Tuesday, January 31, 2017 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Saturday, January 28, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, January 28, 2017 | NEW APPLICATION ENTERED |